Founders Friedrich Bayer Johann Friedrich Weskott


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 24
Average round size
The average size of a deal this fund participated in
Portfolio companies 22
Rounds per year 0.15
Lead investments 11
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees 3

Areas of investment

  • Health Care
  • Biotechnology
  • Life Science
  • Medical
  • Agriculture

Bayer is the famous Corporate Investor, which was founded in 1863. The main office of represented Corporate Investor is situated in the Leverkusen. The fund was located in Europe if to be more exact in Germany.

Among the most popular portfolio startups of the fund, we may highlight BlueRock Therapeutics, OneDrop, Arvegenix. Among the most popular fund investment industries, there are Biotechnology, Agriculture. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Bayer, startups are often financed by Launch Fund, The Yield Lab, St. Louis Arch Angels. The meaningful sponsors for the fund in investment in the same round are Viking Global Investors, Ginkgo Bioworks, ARCH Venture Partners. In the next rounds fund is usually obtained by Viking Global Investors, Ginkgo Bioworks.

Deals in the range of 50 - 100 millions dollars are the general things for fund. Speaking about the real fund results, this Corporate Investor is 38 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2019. When the investment is from Bayer the average startup value is 5-10 millions dollars. Comparing to the other companies, this Bayer performs on 21 percentage points less the average number of lead investments. The top amount of exits for fund were in 2019.

This organization was formed by Friedrich Bayer, Johann Friedrich Weskott.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Bayer:
Typical Co-investors
Bayer is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Bayer:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aligned Partners California, Menlo Park, United States
Bethesda venture capital -
Citizen's Capital Boston, Massachusetts, United States
CKD Venture Capital Corporation Seoul, Seoul-t'ukpyolsi, South Korea
Exponential Partners California, Corona Del Mar, United States
Falcon Edge India Cayman Islands, Grand Cayman
Hella Ventures California, Sunnyvale, United States
Highland Creek Partners Canada, Ontario, Toronto
Huabin Venture Capital China, Shanghai
Koudai Information Technology China, Hangzhou, Zhejiang
Linic Ltd -
m-pathy Dresden, Germany, Sachsen
New York Life Investment Management New York, New York, United States
Northwest Ohio Tech Fund II -
Phoenix Tree Capital Partners Beijing, Beijing, China
Seiho Investment Works Hokkaido Prefecture, Japan, Sapporo
Shanghai Lemeng Shiye Co., Ltd China, Shanghai
Sino AG -
Vista Venture Partners California, Palo Alto, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Grão Direto

Trading Platform
$3M01 Mar 2021 Brazil, Mato Grosso, Brazil


Health Care
Information Technology
$1M17 Nov 2020 Los Angeles, California, United States


Health Care
Medical Device
$34M24 Aug 2020 New York, United States

Oerth Bio

$55M27 Feb 2020 New Haven, Connecticut, United States

Okko Health

Health Care
$394K01 Jan 2020 England

Immunitas Therapeutics

Life Science
$39M22 Nov 2019 Cambridge, Massachusetts, United States


Big Data
Health Care
10 Nov 2019 Bellevue, Washington, United States


Life Science
$100M07 Nov 2019 Cambridge, Massachusetts, United States


Big Data
Health Care
Information Technology
Management Information Systems
$25M05 Nov 2019 England


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Bayer?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: